ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print September 17, 2008, 10.1183/09031936.00142407
Eur Respir J 2009; 33:398-404
Copyright ©ERS Journals Ltd 2009
doi: 10.1183/09031936.00142407

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/2/398    most recent
09031936.00142407v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, J.
Right arrow Articles by Bai, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, J.
Right arrow Articles by Bai, C.

Effects of curcumin or dexamethasone on lung ischaemia–reperfusion injury in rats

J. Sun1, D. Yang1, S. Li1, Z. Xu2, X. Wang1 and C. Bai1

1 Dept of Pulmonary Medicine, Zhongshan Hospital, Fudan University, and 2 Dept of Pathology, Fudan University, Shanghai, China.

CORRESPONDENCE: C. Bai, Dept of Pulmonary Medicine, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, 200032, China. Fax: 86 2154961729. E-mail: bai.chunxue{at}zs-hospital.sh.cn

Keywords: Curcumin, ischaemia–reperfusion, lung, microvascular permeability, nuclear factor-{kappa}B, oxidative stress

Received: October 28, 2007
Accepted August 29, 2008

The present study aimed to investigate potential effects of curcumin (CUR) and dexamethasone (DXM) on ischaemia–reperfusion (I/R) induced lung injury in rats.

Experimental rats were pre-treated with a single i.p. dose of vehicle, CUR (50 mg·kg–1 or 200 mg·kg–1) or DXM (5 mg·kg–1), 2 h before anaesthesia and subjected to left lung hilus clamping with 90-min ischaemia followed by 4 h of reperfusion.

Pre-treatment with CUR (200 mg·kg–1) or DXM markedly attenuated I/R-induced barrier disruption, lung oedema, tissue inflammation, hypoxaemia 4 h after reperfusion, and overactivation of nuclear factor-{kappa}B, inflammatory cytokines, myeloperoxidase and malondialdehyde.

It appears that curcumin attenuates acute lung injury, probably through improving oxidative stress and inhibiting nuclear factor-{kappa}B-mediated expression of inflammatory cytokines. Thus, curcumin may be an alternative therapy for improving the outcomes of ischaemia–reperfusion-induced lung injury.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.